Home > Insider Trading > Filing (0001562180-22-006777)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1603756	Axonics Inc.	AXNX	Surgical & Medical Instruments & Apparatus (3841)	454744083

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1756240	Karen Noblett	26 Technology Drive Irvine CA 92618	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-09-12	18,519	$14.19	50,118	No	4	M	Direct
Common Stock	Acquisiton	2022-09-12	13,964	$25.82	64,082	No	4	M	Direct
Common Stock	Disposition	2022-09-12	32,483	$78.16	31,599	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-09-12	18,519	$0.00	18,519	$14.19
Common Stock	Stock Options (Right to buy)	Disposition	2022-09-12	13,964	$0.00	13,964	$25.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,963		2029-01-30	No	4	M	Direct
6,348		2029-12-12	No	4	M	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $78.00 to $78.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.
The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date.